In 2023, GSK conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, GSK generated a total of 49,700 metric tonnes of waste.
Of this amount, 52.72% of GSK's total waste generated was recovered through methods such as recycling, reuse, or composting, while 47.28% was disposed of through landfilling, incineration, or combustion.
In 2023, GSK reported a total waste generation of 49,700 metric tonnes, of which 52.72% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that GSK is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Since 2020, GSK's total waste generation decreased by 21.11%, including a further 1.19% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.
Over the same period, GSK's waste recovery rate increased by 21.63%.
In 2023, GSK generated a total of 49,700 metric tonnes of waste.
Of this amount, 36.82% of GSK's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 63.18% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2020, GSK's total waste generation decreased by 21.11%, with an additional 1.19% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.
Over the same period, GSK reduced the hazardousness of its waste by 9.74%, with a further 3.54% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, GSK has made consistent and substantial progress in reducing both the quantity and the danger of its waste, highlighting a strong, well-executed waste strategy focused on minimizing environmental impact.
In 2023, GSK reported that 18,300 metric tonnes of its total waste output were classified as hazardous. This represents 36.82% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Approximately 19.67% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.